Update of Practice Guidelines for the Management of Community-Acquired Pneumonia in Immunocompetent Adults
McMaster University · Johns Hopkins University · +3 more institutions
Abstract
Recent antibiotic therapy b A respiratory fluoroquinolone c alone, an advanced macrolide d plus high-dose amoxicillin, e or an advanced macrolide plus high-dose amoxicillin-clavulanate f Comorbidities (COPD, diabetes, renal or congestive heart failure, or malignancy) No recent antibiotic therapy An advanced macrolide d or a respiratory fluoroquinolone Recent antibiotic therapy A respiratory fluoroquinolone c alone or an advanced macrolide plus a b-lactam g Suspected aspiration with infection Amoxicillin-clavulanate or clindamycin Influenza with bacterial superinfection A b-lactam g or a respiratory fluoroquinolone Inpatient Medical ward No recent antibiotic therapy A respiratory fluoroquinolone alone or an…
Citation impact
- FWCI
- 90.58
- Percentile
- 100%
- References
- 254
Authors
6Topics & keywords
- Medicine
- Community-acquired pneumonia
- Pneumonia
- Empiric therapy
- Intensive care medicine
- MEDLINE
- Family medicine
- Alternative medicine
- Good health and well-being